1 2232 139 THE IMPACT OF YOGA ON INSPIRATORY MUSCLE PERFORMANCE IN VETERANS WITH COPD: A PILOT STUDY. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) CAUSES RESPIRATORY MUSCLE WEAKNESS THAT LEADS TO DISABLING DYSPNEA AND POOR FUNCTIONAL PERFORMANCE. THERAPIES ARE OFTEN GEARED TO IMPROVE INSPIRATORY MUSCLE PERFORMANCE. YOGA HAS BEEN SHOWN TO IMPROVE EXERCISE CAPACITY, QUALITY OF LIFE, AND SOME PULMONARY FUNCTION MEASURES IN COPD, BUT LITTLE RESEARCH HAS EXAMINED THE EFFECTS OF YOGA TRAINING ON INSPIRATORY MUSCLE PERFORMANCE. THE PURPOSE OF THIS STUDY WAS TO INVESTIGATE THE EFFECTS OF YOGA TRAINING ON INSPIRATORY MUSCLE PERFORMANCE IN MILITARY VETERANS USING THE TEST OF INCREMENTAL RESPIRATORY ENDURANCE (TIRE). A PROSPECTIVE PILOT STUDY EXAMINED A 6-WEEK YOGA TRAINING PROGRAM CONSISTING OF ASANA (POSES) AND PRANAYAMA (CONTROLLED BREATHING). SUBJECTS HAD BASELINE INSPIRATORY MUSCLE WEAKNESS. THE TIRE MEASURED INSPIRATORY MUSCLE PERFORMANCE VIA THE PRO2 DEVICE, PROVIDING MAXIMAL INSPIRATORY PRESSURE, SUSTAINED MAXIMAL INSPIRATORY PRESSURE, AND INSPIRATORY DURATION. SECONDARY MEASURES INCLUDED 6-MINUTE WALK DISTANCE, ST. GEORGE RESPIRATORY QUESTIONNAIRE, HOSPITAL ANXIETY AND DEPRESSION SCALE, AND SPIROMETRY. MEAN AGE AND BMI OF SUBJECTS WERE 67 +/- 3.6 YEARS AND 20.7 +/- 3.3, RESPECTIVELY. THE MAJORITY OF SUBJECTS HAD SEVERE (28.7%) OR VERY SEVERE (57.1%) COPD. STATISTICALLY SIGNIFICANT IMPROVE M E N T S WERE SEEN IN MAXIMAL INSPIRATORY PRESSURE (39.0 +/- 14.1 CMH2O TO 56.4 +/- 20.6 CMH2O) AND SUSTAINED MAXIMAL INSPIRATORY PRESSURE (244.1 +/- 100.6 PTU TO 308.1 +/- 121.2 PTU). NO STATISTICALLY SIGNIFICANT IMPROVEMENTS WE RE OBSERVED IN 6-MINUTE WALK DISTANCE, ST. GEORGE RESPIRATORY QUESTIONNAIRE, HOSPITAL ANXIETY AND DEPRESSION SCALE, OR SPIROMETRY. YOGA TRAINING HAS THE POTENTIAL IN IMPROVE INSPIRATORY MUSCLE PERFORMANCE IN VETERANS WITH SEVERE TO VERY SEVERE COPD WHO PRESENT WITH INSPIRATORY MUSCLE WEAKNESS. THIS IS OF IMPORTANCE BECAUSE IMPROVING INSPIRA-TORY MUSCLE PERFORMANCE HAS BEEN SHOWN TO IMPROVE COPD OUTCOMES. 2021 2 792 47 EFFECT OF YOGA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. YOGA IS ADJUNCTIVELY UTILIZED OUTSIDE THE UNITED STATES IN THE TREATMENT OF A VARIETY OF DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD), BUT THERE ARE NO STUDIES ASSESSING ITS ADJUNCTIVE EFFICACY IN THE UNITED STATES. WE PROSPECTIVELY EVALUATED THE EFFECTS OF YOGA TRAINING ON THE QUALITY OF LIFE (QOL) AND THE PARAMETERS OF LUNG FUNCTION IN PATIENTS WITH COPD. THIRTY-THREE PATIENTS WITH DOCUMENTED COPD, PER GLOBAL INITIATIVE FOR OBSTRUCTIVE LUNG DISEASE CRITERIA, WERE RECRUITED. ALL PATIENTS RECEIVED STANDARD COPD CARE. THE QOL WAS ASSESSED BY THE ST. GEORGE RESPIRATORY QUESTIONNAIRE. STANDARD SPIROMETRY AND MAXIMUM INSPIRATORY (MAXIMAL INSPIRATORY PRESSURE) AND EXPIRATORY PRESSURE (MAXIMAL EXPIRATORY PRESSURE) WERE MEASURED. PATIENTS WERE TAUGHT SELECTED YOGA EXERCISES INCLUDING BREATHING EXERCISES, MEDITATION, AND YOGA POSTURES FOR 1 HOUR, THRICE A WEEK FOR 6 WEEKS BY A CERTIFIED YOGA THERAPIST. THE QUALITY OF LIFE AND LUNG FUNCTION WERE AGAIN ASSESSED AT THE END OF 6 WEEKS. TWENTY-TWO PATIENTS COMPLETED THE STUDY. DIFFERENCES IN PREYOGA VERSUS POSTYOGA SCORES WERE EVALUATED USING PAIRED T-TESTS. STATISTICALLY SIGNIFICANT IMPROVEMENTS (P < 0.05) WERE OBSERVED FOR THE ST. GEORGE RESPIRATORY QUESTIONNAIRE [95% CONFIDENCE INTERVAL (CI) 43.13-58.47], VITAL CAPACITY (95% CI 2.53-7.65), MAXIMAL INSPIRATORY PRESSURE (95% CI 6.62-23.64), AND MAXIMAL EXPIRATORY PRESSURE (95% CI 1.63-13.81). YOGA WHEN PRACTICED BY PATIENTS WITH COPD RESULTS IN IMPROVEMENT IN THE QOL AND LUNG FUNCTION ON A SHORT-TERM BASIS. ADDITIONAL RESEARCH IS NEEDED TO CONFIRM THESE FINDINGS IN A RANDOMIZED CONTROLLED TRIAL AND IN THE LONGER TERM. 2012 3 2823 30 YOGA VERSUS AEROBIC ACTIVITY: EFFECTS ON SPIROMETRY RESULTS AND MAXIMAL INSPIRATORY PRESSURE. OBJECTIVE: TO CLARIFY WHETHER, IN HEALTHY INDIVIDUALS, PRACTICING YOGA CAN MODIFY MAXIMAL INSPIRATORY PRESSURE AND SPIROMETRIC INDICES WHEN COMPARED WITH THE PRACTICE OF AEROBIC EXERCISE. MEYHODS: A CONTROLLED CLINICAL TRIAL. A TOTAL OF 31 HEALTHY VOLUNTEERS WERE ALLOCATED TO PRACTICE AEROBIC EXERCISE (N = 15) OR TO PRACTICE YOGA (N = 16). THOSE IN THE FIRST GROUP SERVED AS CONTROLS AND ENGAGED IN AEROBIC EXERCISE FOR 45-60 MINUTES, TWICE A WEEK FOR THREE MONTHS. THOSE IN THE SECOND GROUP PRACTICED SELECTED YOGIC TECHNIQUES, ALSO IN SESSIONS OF 45-60 MINUTES, TWICE A WEEK FOR THREE MONTHS. FORCED VITAL CAPACITY, FORCED EXPIRATORY VOLUME IN ONE SECOND AND MAXIMAL INSPIRATORY PRESSURE WERE MEASURED BEFORE AND AFTER THE THREE MONTHS OF TRAINING. RESULTS: NO SIGNIFICANT ALTERATIONS WERE SEEN IN THE SPIROMETRIC INDICES. A SLIGHT, ALTHOUGH NOT SIGNIFICANT, IMPROVEMENT IN MAXIMAL INSPIRATORY PRESSURE WAS SEEN IN BOTH GROUPS. HOWEVER, THERE WAS A SIGNIFICANT DIFFERENCE, SEEN IN BOTH GENDERS, BETWEEN THE ABSOLUTE DELTA (FINAL VALUE MINUS BASELINE VALUE) OF MAXIMAL INSPIRATORY PRESSURE FOR THE GROUP PRACTICING YOGA AND THAT OBTAINED FOR THE GROUP ENGAGING IN AEROBIC EXERCISE (MALES: 19.5 CM H2O VERSUS 2.8 CM H2O, P = 0.05; FEMALES: 20 CM H2O VERSUS 3.9 CM H2O, P = 0.01). CONCLUSION: NEITHER YOGA NOR AEROBIC EXERCISE PROVIDED A STATISTICALLY SIGNIFICANT IMPROVEMENT IN MAXIMAL INSPIRATORY PRESSURE AFTER THREE MONTHS. HOWEVER, THE ABSOLUTE VARIATION IN MAXIMAL INSPIRATORY PRESSURE WAS GREATER AMONG THOSE PRACTICING YOGA. 2006 4 822 30 EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE (6-MWD) AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B. INTRODUCTION: YOGA IS USED IN THE TREATMENT OF VARIOUS DISEASES, INCLUDING CHRONIC OBSTRUCTIVE PULMONARY DISEASE. HOWEVER, NO STUDIES HAVE ASSESSED THE EFFECT OF YOGA ON COPD PATIENTS IN INDONESIA. THE DIFFERENCE BETWEEN THIS STUDY AND SIMILAR STUDIES COMPLETED IN OTHER COUNTRIES LIES IN THE TYPE OF YOGA EXERCISES COMPLETED, THE METHOD IN WHICH THEY WERE COMPLETED, AND IN CERTAIN, UNIQUE DEMOGRAPHIC CHARACTERISTICS. THIS STUDY AIMS TO ANALYZE THE EFFECT OF YOGA ON FEV1, 6-MINUTE WALK DISTANCE, AND QUALITY OF LIFE IN PATIENTS WITH COPD GROUP B IN INDONESIA. MATERIAL AND METHODS: THIS ARTICLE REFLECTS RESEARCH DONE IN THE FORM OF AN EXPERIMENTAL STUDY USING ARANDOMIZED CONTROLLED TRIAL WITH PRE AND POST-TEST CONTROL GROUP DESIGN. THE SAMPLES WERE DIVIDED INTO 2 GROUPS: THE TREATMENT GROUP (YOGA PRACTICE FOR 1 HOUR, 2 TIMES AWEEK FOR 12 WEEKS) AND THE CONTROL GROUP (UNTREATED WITH YOGA, GIVEN LUNG REHABILITATION BROCHURE). ASSESSMENT OF THE EFFECT OF YOGA EXERCISES ON LUNG FUNCTION PARAMETERS (FEV1), 6-MINUTE WALK DISTANCE AND QUALITY OF LIFE WERE USED USING SGRQ QUESTIONNAIRES IN COPD GROUP B. RESULTS: 33 COPD PATIENTS FULFILLED THE INCLUSION CRITERIA. 30 PATIENTS COMPLETED THE STUDY. PRE AND POST YOGA RESULTS WERE EVALU-ATED IN THE TREATMENT GROUP VERSUS THE CONTROL GROUP AND THEN FURTHER ASSESSED USING STATISTICAL TESTS. THERE WAS ASIGNIFICANT IN-CREASE IN FEV1, 6-MWD AND QUALITY OF LIFE USING ASGRQ QUESTIONNAIRE AFTER 12 WEEKS OF YOGA (P < 0.05) AS WELL AS AASIGNIFICANT CHANGE IN FEV1, 6-MWD AND QUALITY OF LIFE IN THE TREATMENT GROUP (P < 0.05) WHEN COMPARED WITH THE CONTROL GROUP (P > 0.05). CONCLUSIONS: YOGA AFFECTS FEV1, 6-MWD, AND QUALITY OF LIFE IN PATIENTS WITH GROUP B COPD. 2019 5 2173 32 THE EFFECTS OF YOGA ON DYSPNEA, SLEEP AND FATIGUE IN CHRONIC RESPIRATORY DISEASES. PURPOSE: THIS STUDY WAS CARRIED OUT TO FIND OUT THE EFFECTS OF YOGA APPLIED TO CHRONIC RESPIRATORY DISEASE PATIENTS ON DYSPNEA, SLEEP QUALITY AND FATIGUE. MATERIAL AND METHOD: THE STUDY WAS CONDUCTED BETWEEN MAY AND AUGUST 2020 AS A RANDOMIZED CONTROLLED STUDY. 'PERSONAL INFORMATION FORM', 'RESPIRATORY FUNCTIONS MONITORING FORM', 'COPD AND ASTHMA FATIGUE SCALE (CAFS), "ASTHMA AND COPD SLEEP IMPACT SCALE (CASIS)" AND MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE (MMRC) WERE USED IN DATA COLLECTION. RESULTS: WHEN THE POST-TEST MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL AND CONTROL GROUP WERE COMPARED, IT WAS FOUND THAT CAFS, CASIS AND MMRC MEAN SCORES OF THE PATIENTS IN THE EXPERIMENTAL GROUP DECREASED POSITIVELY COMPARED TO THE PATIENTS IN THE CONTROL GROUP AND THE DIFFERENCE BETWEEN WAS FOUND TO BE STATISTICALLY SIGNIFICANT (P < 0.05). CONCLUSION: YOGA HAS BEEN FOUND TO REDUCE THE SEVERITY OF DYSPNEA AND FATIGUE AND IMPROVE SLEEP QUALITY IN CHRONIC RESPIRATORY DISEASES. 2021 6 2662 40 YOGA IN BURN: ROLE OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL-THICKNESS CIRCUMFERENTIAL BURNS OF THE CHEST. BACKGROUND: CIRCUMFERENTIAL BURN OF CHEST (CBC) IS A SIGNIFICANT TYPE OF BURN AND CONSIDERS AS A MAJOR CAUSE OF RESTRICTIVE LUNG DISEASE (RLD). PATIENT WHO HAS CBC WITH RLD LEADS TO RESPIRATORY SYMPTOMS SUCH AS BREATHING DIFFICULTY, AIRWAY OBSTRUCTION, REDUCED EXERCISE CAPACITY AND ALTERED PULMONARY FUNCTIONS. HOWEVER, STUDIES EXAMINING THE ROLE OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL THICKNESS CIRCUMFERENTIAL BURN OF CHEST ARE LACKING. OBJECTIVE: TO FIND THE SHORT TERM EFFECTS OF PRANAYAMA BREATHING EXERCISE ON PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY AND EXERCISE TOLERANCE IN FULL THICKNESS CIRCUMFERENTIAL BURNS OF CHEST. METHODS: THROUGH SIMPLE RANDOM SAMPLING METHOD THIRTY SUBJECTS (N = 30) WITH RLD FOLLOWING CBC WERE ALLOCATED TO PRANAYAMA BREATHING EXERCISE GROUP (PBE-G; N = 15) AND CONVENTIONAL BREATHING EXERCISE GROUP (CBE-G; N = 15). THEY RECEIVED PRANAYAMA BREATHING EXERCISE AND CONVENTIONAL BREATHING EXERCISE FOR 4 WEEKS RESPECTIVELY. ALL THE SUBJECTS RECEIVED CHEST MOBILITY EXERCISE AS COMMON TREATMENT. PRIMARY (NUMERIC PAIN RATING SCALE - NPRS, FORCED EXPIRATORY VOLUME (FEV1), FORCED VITAL CAPACITY (FVC) AND MAXIMUM VOLUNTARY VENTILATION (MVV) AND SECONDARY (ELECTROMYOGRAM OF STERNOCLEIDOMASTOID, SCALENE, EXTERNAL INTERCOSTAL AND DIAPHRAGM MUSCLE, 6 MIN WALK TEST & GLOBAL RATING OF CHANGE - GRC) OUTCOME MEASURES WERE MEASURED AT BASELINE, AFTER FOUR WEEKS AND AFTER THREE MONTHS FOLLOW UP. RESULTS: BASELINE DEMOGRAPHIC AND CLINICAL VARIABLES SHOW HOMOGENOUS DISTRIBUTION BETWEEN THE GROUPS (P > 0.05). FOUR WEEKS FOLLOWING DIFFERENT BREATHING EXERCISES, PBE-G GROUP SHOWS MORE SIGNIFICANT CHANGES IN PAIN INTENSITY, PULMONARY FUNCTION, RESPIRATORY MUSCLE ACTIVITY, EXERCISE TOLERANCE AND GLOBAL RATING OF CHANGE THAN CBE-G GROUP (P